This is a summary of the European public assessment report (EPAR) for Duaklir Genuair. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Duaklir Genuair. For practical information about using Duaklir Genuair, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Duaklir Genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Therapeutic Area (MeSH)
ATC Code
R03AL
ATC Item
抗胆碱能与抗胆碱能结合/三重组合与糖皮质激素
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| aclidinium bromide | N/A | 阿地溴铵 |
| formoterol fumarate dihydrate | N/A | Aluminum sulfate |
EMA Name
Duaklir Genuair
Medicine Name
Duaklir Genuair
Aliases
N/A
